Valedictory session of Certificate course in ‘Patenting of NDDS and Specialty [505(b)(2)] products’
via https://youtu.be/xV4EyTMNvNY
China-India joint summit discusses bilateral trade to improve pharma industry
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues. Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour. Among other dignitaries, Dr. Anil Kumar Rai, Consulate General of
Comments
Post a Comment